hypogonadism; t therapy; cvd; fda

  1. madman

    Some of the biggest questions facing men’s health and urology today

    https://www.urologytimes.com/view/pearls-perspectives-helen-bernie-do-mph-at-aua-2025 In this episode of Pearls and Perspectives from Urology Times, host Amy Pearlman, MD, sits down with Helen Bernie, DO, MPH, at the American Urological Association's (AUA) 2025 Annual Meeting in Las Vegas for...
  2. madman

    Testosterone and Cardiovascular Risk: The TRAVERSE Trial and Results from the New FDA Label Change

    Mohit Khera, MD, MBA, MPH, Professor of Urology and F. Brantley Scott Chair of Urology, Baylor College of Medicine, Houston, Texas, discusses evolving understanding of testosterone therapy and cardiovascular risk. In this 13-minute presentation, Dr. Khera focuses on the pivotal TRAVERSE trial...
Back
Top